VISHEE(688580)2025-04-24 14:25Financial Performance - The net profit attributable to shareholders for 2024 is RMB 101,969,230.54, with a total distributable profit of RMB 407,359,759.90 as of December 31, 2024[6]. - The company's total revenue for 2024 was CNY 400.06 million, a decrease of 13.45% compared to CNY 462.22 million in 2023[25]. - Net profit attributable to shareholders for 2024 was CNY 101.97 million, down 25.16% from CNY 136.26 million in 2023[25]. - The basic earnings per share for 2024 was CNY 1.0685, reflecting a decline of 25.07% from CNY 1.4260 in 2023[26]. - The cash flow from operating activities for 2024 was CNY 118.29 million, down 11.86% from CNY 134.20 million in 2023[25]. - The company's total assets at the end of 2024 were CNY 1,820.36 million, an increase of 0.79% from CNY 1,806.02 million at the end of 2023[25]. - The net assets attributable to shareholders at the end of 2024 were CNY 1,627.46 million, showing a slight increase of 0.04% from CNY 1,626.76 million in 2023[25]. - The company's total revenue for 2024 was 395.34 million, a decrease of 13.20% compared to the previous year[139]. - The gross profit margin for the overall business was 65.08%, reflecting a decrease of 2.24 percentage points compared to the previous year[137]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 8 per 10 shares, totaling approximately RMB 76,569,346.40, which represents 88.45% of the net profit for the year[8]. - No capital reserve fund will be converted into share capital, and no bonus shares will be issued, with remaining undistributed profits carried forward[8]. Research and Development - Research and development expenses accounted for 16.45% of total revenue in 2024, a decrease of 0.52 percentage points from 16.97% in 2023[26]. - The company obtained 17 new patents during the reporting period, including 10 invention patents, bringing the total to 255 authorized patents[38]. - Total R&D expenditure decreased by 16.10% year-on-year, amounting to ¥65,802,296.31[108]. - The company has established six major technology platforms, including magnetic stimulation and laser technology, enhancing its core competitive advantage[118]. - The company is committed to continuous innovation and product development, aiming to align with global benchmarks and drive the advancement of rehabilitation technology[175]. Product Development and Innovation - The company focuses on rehabilitation technologies for postpartum conditions such as urinary incontinence and pelvic pain[15]. - The company has developed a neuromuscular electrical stimulation technology aimed at functional recovery through targeted muscle stimulation[15]. - The company is engaged in research and development of transcranial magnetic stimulation (TMS) technology for cognitive and motor function improvement[16]. - The company launched the MagNeuro ONE series transcranial magnetic stimulation device, enhancing its competitive advantage in the mental rehabilitation equipment sector[38]. - The company has developed a miniaturized high-pressure medical power supply for magnetic stimulation products, meeting output requirements of 150Hz pulse frequency and 6 Tesla magnetic field strength[97]. Market Expansion and Strategy - The company is actively pursuing international market expansion, seeking strategic partnerships with global collaborators to build a cross-border academic promotion network[54]. - The company plans to expand its market share in rehabilitation by enhancing its product matrix in postpartum recovery, psychological rehabilitation, and pediatric rehabilitation[37]. - The marketing strategy includes expanding into grassroots and private medical markets, optimizing the sales network, and increasing market penetration in gynecology and urology departments, aiming for new sales breakthroughs[180]. Corporate Governance - The company held 2 shareholder meetings during the reporting period, complying with relevant laws and regulations[189]. - A total of 6 board meetings were conducted, with independent directors attending and providing independent opinions[190]. - The independent directors actively participated in board discussions and decision-making on significant matters[192]. - The company approved 15 resolutions at the shareholder meetings, including the 2023 annual financial budget and profit distribution plan[193]. Risk Management - The company has detailed various risks and countermeasures in its annual report[3]. - The company is focusing on ensuring that product development aligns with market demand to address potential risks in technology and product competitiveness[127]. - The company is actively monitoring industry policies and regulations to adapt its strategies accordingly, minimizing risks from regulatory changes[131]. Customer Engagement and Satisfaction - Customer satisfaction ratings improved to 90%, reflecting a 5% increase from the last quarter[200]. - The company is focusing on improving user engagement through the optimization of its smart cloud products, reducing maintenance costs and enhancing operational efficiency[114]. Employee Incentives and Retention - The company has implemented a multi-layered incentive mechanism, aligning employee contributions with corporate value growth[126]. - The overall increase in shares and stock incentives indicates a positive outlook for employee engagement and future growth potential[197].